Association of the predicted free blood concentration of teicoplanin with the development of renal dysfunction

Kyohei Sugiyama1, Keita Hirai2,3, Yukako Suyama4

  • 1Department of Pharmacy, Shizuoka General Hospital, 4-27-1 Kita Ando Aoi-Ku, Shizuoka, 420-8527, Japan. kyohei-sugiyama@i.shizuoka-pho.jp.

Abstract

Insights

Elevated free teicoplanin (TEIC) levels increase the risk of kidney damage. Monitoring and controlling free TEIC concentrations can help prevent renal dysfunction in patients.

Area of Science:

  • Pharmacology
  • Nephrology
  • Clinical Pharmacy

Background:

  • Teicoplanin (TEIC) is commonly used in clinical settings.
  • TEIC exhibits high protein binding (around 90%).
  • The relationship between free TEIC concentrations and renal dysfunction is not fully understood.

Purpose of the Study:

  • To investigate the impact of predicted free teicoplanin blood concentration on the development of renal dysfunction.
  • To clarify the association between free TEIC trough concentration and renal dysfunction incidence.

Main Methods:

  • Retrospective study design.
  • Inclusion of patients with TEIC treatment and trough concentration measurements.
  • Calculation of predicted free TEIC concentration using the formula: total TEIC concentration / (1 + 1.78 × serum albumin level).

Main Results:

  • 18% of patients (31/170) developed renal dysfunction.
  • Significantly higher predicted free trough TEIC concentrations were observed in the renal dysfunction group.
  • Total trough TEIC concentration was not significantly associated with renal dysfunction.
  • An increased risk of renal dysfunction (OR 4.5) was noted when predicted free trough TEIC exceeded 4.0 µg/mL.

Conclusions:

  • Elevated free teicoplanin trough concentrations are linked to a higher risk of renal dysfunction.
  • Managing and controlling predicted free TEIC blood concentrations may be crucial for preventing renal dysfunction.

Related Concept Videos

Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
89
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
95
Drug Elimination by Renal Route: Tubular Secretion01:15

Drug Elimination by Renal Route: Tubular Secretion

Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
2.4K
Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
185
Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions01:09

Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions

Renal clearance plays a pivotal role in drug elimination from the body and can be influenced by drug distribution and interactions. Understanding these factors is crucial in pharmacology as they impact the effectiveness and duration of drug therapy.
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
131
Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels01:31

Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels

Renal clearance of a drug is influenced by various factors, including its physicochemical properties and plasma levels. These factors play a significant role in determining how efficiently the kidneys eliminate a drug.
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
229